tradingkey.logo

Elevance Health Inc

ELV
315.190USD
-6.760-2.10%
Horarios del mercado ETCotizaciones retrasadas 15 min
69.98BCap. mercado
12.65P/E TTM

Elevance Health Inc

315.190
-6.760-2.10%

Más Datos de Elevance Health Inc Compañía

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Información de Elevance Health Inc

Símbolo de cotizaciónELV
Nombre de la empresaElevance Health Inc
Fecha de salida a bolsaOct 30, 2001
Director ejecutivoMs. Gail K. Boudreaux
Número de empleados103158
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 30
Dirección220 Virginia Avenue
CiudadINDIANAPOLIS
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46204
Teléfono18003311476
Sitio Webhttps://www.elevancehealth.com/
Símbolo de cotizaciónELV
Fecha de salida a bolsaOct 30, 2001
Director ejecutivoMs. Gail K. Boudreaux

Ejecutivos de Elevance Health Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--

Desglose de ingresos

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%

Estadísticas de accionistas

Actualizado: dom., 26 de oct
Actualizado: dom., 26 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
5.23%
State Street Investment Management (US)
4.76%
T. Rowe Price Associates, Inc.
3.49%
Capital International Investors
2.92%
Otro
73.37%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
5.23%
State Street Investment Management (US)
4.76%
T. Rowe Price Associates, Inc.
3.49%
Capital International Investors
2.92%
Otro
73.37%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.91%
Investment Advisor/Hedge Fund
31.90%
Bank and Trust
2.47%
Pension Fund
2.44%
Research Firm
2.01%
Hedge Fund
1.73%
Sovereign Wealth Fund
1.42%
Family Office
0.27%
Family Office
0.27%
Otro
4.59%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
3047
209.27M
92.93%
-7.67M
2025Q2
3093
215.32M
95.62%
-4.57M
2025Q1
3135
209.98M
92.91%
-9.57M
2024Q4
3098
213.30M
93.78%
-5.08M
2024Q3
3004
212.78M
91.75%
-6.27M
2024Q2
2973
214.50M
92.28%
-4.31M
2024Q1
2940
212.64M
91.38%
-6.83M
2023Q4
2879
214.42M
91.26%
-6.60M
2023Q3
2767
215.95M
91.62%
-5.63M
2023Q2
2750
218.40M
92.12%
-4.32M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
22.75M
10.1%
-140.75K
-0.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.62M
5.16%
-183.35K
-1.55%
Jun 30, 2025
State Street Investment Management (US)
10.57M
4.69%
-78.72K
-0.74%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.75M
3.44%
-1.01M
-11.48%
Jun 30, 2025
Capital International Investors
6.49M
2.88%
+932.14K
+16.78%
Jun 30, 2025
Wellington Management Company, LLP
6.32M
2.81%
+523.40K
+9.03%
Jun 30, 2025
Sanders Capital, LLC
5.83M
2.59%
+1.15M
+24.66%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.09M
2.26%
-72.83K
-1.41%
Jun 30, 2025
Artisan Partners Limited Partnership
3.68M
1.63%
+324.40K
+9.68%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
3.20M
1.42%
-41.22K
-1.27%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
9.06%
Monarch Dividend Plus Index ETF
3.38%
GMO US Quality ETF
2.36%
First Trust Total US Market AlphaDEX ETF
2.2%
Monarch Volume Factor Dividend Tree Index ETF
2.17%
T Rowe Price Equity Income ETF
1.88%
John Hancock Fundamental All Cap Core ETF
1.84%
iShares Large Cap Value Active ETF
1.71%
VictoryShares Free Cash Flow ETF
1.64%
Bushido Capital US Equity ETF
1.63%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción9.06%
Monarch Dividend Plus Index ETF
Proporción3.38%
GMO US Quality ETF
Proporción2.36%
First Trust Total US Market AlphaDEX ETF
Proporción2.2%
Monarch Volume Factor Dividend Tree Index ETF
Proporción2.17%
T Rowe Price Equity Income ETF
Proporción1.88%
John Hancock Fundamental All Cap Core ETF
Proporción1.84%
iShares Large Cap Value Active ETF
Proporción1.71%
VictoryShares Free Cash Flow ETF
Proporción1.64%
Bushido Capital US Equity ETF
Proporción1.63%

Dividendos

Un total de 6.19B USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Apr 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 23, 2023
Jun 08, 2023
Jan 25, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 24, 2023
Mar 09, 2023
Oct 19, 2022
ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022
Dec 05, 2022
Dec 21, 2022
Dec 02, 2022
Ver más

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI